Publications by authors named "David Chernoff"

Claim this Profile
N
Neuroimmune Modulation for Drug-Refractory Rheumatoid Arthritis: Long-Term Safety and Efficacy in Patients Enrolled in a Pilot Vagus Nerve Stimulation Study.
Norman B Gaylis, David Sikes, Alan Kivitz, Diane Lewis Horowitz, Melissa Evangelista, David Chernoff

Rheumatol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trial.
John R P Tesser, Angela R Crowley, Emily Jane Box, Joshua P June, Pendleton Brewster Wickersham, David Chernoff

Nat Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrical stimulation of the vagus nerve ameliorates inflammation and disease activity in a rat EAE model of multiple sclerosis.
Chandramohan Natarajan, Linh H D Le, Manojkumar Gunasekaran, Kevin J Tracey, David Chernoff

Proc Natl Acad Sci U S A· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroimmune Modulation Through Vagus Nerve Stimulation Reduces Inflammatory Activity in Crohn's Disease Patients: A Prospective Open-label Study.
Geert D'Haens, Michael Eberhardson, Zeljko Cabrijan, Silvio Danese, Remco van den Berg, David Chernoff

J Crohns Colitis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the impact of age and adiposity on a multi-biomarker disease activity score before and after adjustment.
Joshua F Baker, Jeffrey R Curtis, David Chernoff, Darl D Flake, Eric Sasso

Clin Rheumatol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Fourth Bioelectronic Medicine Summit "Technology Targeting Molecular Mechanisms": current progress, challenges, and charting the future.
Timir Datta-Chaudhuri, Theodoros Zanos, Eric H Chang, Peder S Olofsson, Stephan Bickel, David Chernoff

Bioelectron Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vagus nerve stimulation in rheumatoid arthritis - Authors' reply.
Mark C Genovese, Yaakov A Levine, David Chernoff

Lancet Rheumatol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of neurostimulation with a miniaturised vagus nerve stimulation device in patients with multidrug-refractory rheumatoid arthritis: a two-stage multicentre, randomised pilot study.
Mark C Genovese, Norman B Gaylis, David Sikes, Alan Kivitz, Diane Lewis Horowitz, David Chernoff

Lancet Rheumatol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing the Inflammatory Reflex for the Treatment of Inflammation-Mediated Diseases.
Yaakov A Levine, Michael Faltys, David Chernoff

Cold Spring Harb Perspect Med· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of ADS-5102 (amantadine) extended release capsules to improve walking in multiple sclerosis: A randomized, placebo-controlled, phase 2 trial.
Jeffrey A Cohen, Samuel F Hunter, Theodore R Brown, Mark Gudesblatt, Ben W Thrower, David N Chernoff

Mult Scler· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of the minimally important difference (MID) in multi-biomarker disease activity (MBDA) test scores: impact of diurnal and daily biomarker variation patterns on MBDA scores.
David Chernoff, P Scott Eastman, Ching Chang Hwang, Darl D Flake, Xingbin Wang

Clin Rheumatol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment.
Marjan Ghiti Moghadam, Femke B G Lamers-Karnebeek, Harald E Vonkeman, Peter M Ten Klooster, Janneke Tekstra, David Chernoff

PLoS One· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial.
Karen Hambardzumyan, Rebecca J Bolce, Saedis Saevarsdottir, Kristina Forslind, Johan K Wallman, David Chernoff

RMD Open· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bacillus coagulans GBI-30, 6086 Modulates Faecalibacterium prausnitzii in Older Men and Women.
Edna P Nyangale, Sean Farmer, Howard A Cash, David Keller, David Chernoff

J Nutr· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.
Karen Hambardzumyan, Rebecca Bolce, Saedis Saevarsdottir, Scott E Cruickshank, Eric H Sasso, David Chernoff

Ann Rheum Dis· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modular analysis of peripheral blood gene expression in rheumatoid arthritis captures reproducible gene expression changes in tumor necrosis factor responders.
Michaela Oswald, Mark E Curran, Sarah L Lamberth, Robert M Townsend, Jennifer D Hamilton, David N Chernoff

Arthritis Rheumatol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of prebiotics on the fecal microbiota of elderly volunteers after dietary supplementation of Bacillus coagulans GBI-30, 6086.
Edna P Nyangale, Sean Farmer, David Keller, David Chernoff, Glenn R Gibson

Anaerobe· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to: 'MBDA: what is it good for?' by Yazici et al.
Ronald van Vollenhoven, Karen Hambardzumyan, David Chernoff, Rebecca Bolce

Ann Rheum Dis· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variations and practice in the care of patients with rheumatoid arthritis: quality and cost of care.
Lisa DeMaria, Maria Czarina Acelajado, Jeff Luck, Hui Ta, David Chernoff

J Clin Rheumatol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of rheumatoid arthritis disease activity test on clinical practice.
John W Peabody, Vibeke Strand, Riti Shimkhada, Rachel Lee, David Chernoff

PLoS One· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a multi-biomarker disease activity test for rheumatoid arthritis.
Michael Centola, Guy Cavet, Yijing Shen, Saroja Ramanujan, Nicholas Knowlton, David Chernoff

PLoS One· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of AQX-1125, a small-molecule SHIP1 activator: Part 2. Efficacy studies in allergic and pulmonary inflammation models in vivo.
Grant R Stenton, Lloyd F Mackenzie, Patrick Tam, Jennifer L Cross, Curtis Harwig, David Chernoff

Br J Pharmacol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity.
Jeffrey R Curtis, Annette H van der Helm-van Mil, Rachel Knevel, Tom W Huizinga, Douglas J Haney, David Chernoff

Arthritis Care Res (Hoboken)· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The significance of HIV viral load assay precision: a review of the package insert specifications of two commercial kits.
David N Chernoff

J Int Assoc Physicians AIDS Care (Chic)· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analysis of HIV-1 viral load assays on subtype quantification: Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Monitor version 1.5.
Tarek Elbeik, W Gregory Alvord, Rapee Trichavaroj, Mark de Souza, Robin Dewar, David Chernoff

J Acquir Immune Defic Syndr· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis